Uropathology. (2021)

• Record Type: Book
• Further Information: Note: Ming Zhou, George Netto, Jonathan I. Epstein.
• Authors: (Pathologist), Zhou, Ming; Netto, George J; Epstein, Jonathan I
• Contents: 1 Anatomy and Histology of the Prostate; 2 Seminal Vesicle/Ejaculatory Duct; 3 Cowper Gland; 4 Benign Prostatic Hyperplasia; 5 Acute Inflammation of the Prostate; 6 Chronic Inflammation of the Prostate; 7 Nonspecific Granulomatous Prostatitis (NSGP); 8 Post-Biopsy Granuloma; 9 Prostatic Xanthoma; 10 Granulomatous Prostatitis of Infectious Etiology; 11 Simple Atrophy; 12 Cystic Atrophy; 13 Postatrophy Hyperplasia (PAH); 14 Partial Atrophy; 15 Adenosis; 16 Sclerosing Adenosis; 17 Cribriform Clear Cell Hyperplasia; 18 Hyperplasia of Mesonephric Remnants; 19 Basal Cell Hyperplasia; 20 Urothelial Metaplasia; 21 Squamous Metaplasia; 22 Mucin Cell Metaplasia; 23 Neuroendocrine Cells Involving the Prostate; 24 Verumontanum Mucosal Gland Hyperplasia; 25 Prostatic Infarct; 26 High-Grade Prostatic Intraepithelial Neoplasia (HGPIN); 27 Intraductal Carcinoma of the Prostate; 28 Prostatic Carcinoma, Usual Variant; 29 Prostatic Carcinoma, Atrophic Variant; 30 Prostatic Carcinoma, Foamy Gland Variant; 31 Prostatic Carcinoma, Pseudohyperplastic Variant; 32 Prostatic Carcinoma, Mucinous Variant; 33 Prostatic Carcinoma, Microcystic Variant; 34 Prostatic Intraepithelial Neoplasia (PIN)-Like Adenocarcinoma; 35 Sarcomatoid Carcinoma; 36 Pleomorphic Giant Cell Carcinoma of the Prostate; 37 Lymphoepithelioma-Like Carcinoma of the Prostate (LELC); 38 Prostate Carcinoma with Squamous Differentiation; 39 Ductal Adenocarcinoma; 40 Prostatic Adenocarcinoma with Neuroendocrine Differentiation; 41 Well-Differentiated Neuroendocrine Tumor; 42 Small Cell Carcinoma, Prostate; 43 Large cell neuroendocrine carcinoma; 43 Prostatic Basal Cell Adenoma; 44 Basal Cell Carcinoma of the Prostate; 45 Squamous Neoplasms Including Squamous Cell and Adenosquamous Carcinoma; 46 Urothelial Carcinoma; 47 Prostatic Stromal Tumors of Uncertain Malignant Potential; 48 Prostatic Stromal Sarcoma; 49 Atypical Glands Suspicious for Low-Grade Prostatic Carcinoma; 50 High-Grade Prostatic Intraepithelial Neoplasia with Adjacent Atypical Glands; 51 Radiation-Induced Changes; 52 Hormonal Ablation-Induced Changes; 53 Cryoablation Therapy-Induced Changes; 54 Immunohistochemical Work-Up of Prostate Carcinoma; 55 Gleason Grading of Prostate Carcinoma; 56 Prostate Cancer Staging in Radical Prostatectomy; 57 Genetics and Genomics in Prostate Cancer; 58 Work-Up of "Vanishing" Cancer in Radical Prostatectomy; 59 Nonprostatic Adenocarcinoma Involving the Prostate; 60 Anatomy and Histology of Seminal Vesicles; 61 Amyloidosis; 62 Seminal Vesicle Adenocarcinoma; 63 Mixed Epithelial and Stromal Tumor; 64 Anatomy and Histology of the Urinary Bladder; 65 von Brunn's Nests; 66 Cystitis Cystica et Glandularis; 67 Squamous Metaplasia; 68 Intestinal Metaplasia; 69 Nephrogenic Metaplasia/Adenoma; 70 Polypoid and Papillary Cystitis; 71 Follicular Cystitis; 72 Giant Cell Cystitis; 73 Interstitial Cystitis/Painful Bladder Syndrome; 74 Eosinophilic Cystitis; 75 Infectious Cystitis; 76 Malakoplakia; 77 Granulomatous Cystitis After BCG; 78 Radiation Cystitis; 79 Chemotherapy-Induced Cystitis; 80 Endometriosis of the Bladder; 81 Bladder Endocervicosis; 82 Bladder Exstrophy; 83 Urachal Anomaly; 84 Bladder Diverticulum; 85 Ectopic Prostate Tissue; 86 Urothelial Proliferation of Uncertain Malignant Potential; 87 Reactive Urothelial Atypia; 88 Urothelial Atypia of Unknown Significance; 89 Urothelial Dysplasia; 90 Urothelial Carcinoma In Situ; 91 Urothelial Papilloma; 92 Inverted Papilloma; 93 Papillary Urothelial Neoplasm of Low Malignant Potential; 94 Low-Grade Papillary Urothelial Carcinoma; 95 High-Grade Papillary Urothelial Carcinoma; 96 Invasive Urothelial Carcinoma; 97 Urothelial Carcinoma with Inverted Growth Pattern; 98 Urothelial Carcinoma with Squamous Differentiation; 99 Urothelial Carcinoma with Villoglandular Differentiation; 100 Urothelial Carcinoma, Plasmacytoid Variant; 101 Urothelial Carcinoma, Nested Variant; 102 Urothelial Carcinoma, Micropapillary Variant; 103 Urothelial Carcinoma, Microcystic Variant; 104 Urothelial Carcinoma, Lymphoepithelioma-Like Carcinoma Variant; 105 Urothelial Carcinoma, Clear Cell (Glycogen-Rich) Variant; 106 Lipid-Rich Urothelial Carcinoma; 107 Urothelial Carcinoma, Giant Cell Variant; 108 Urothelial Carcinoma with Syncytiotrophoblastic Giant Cells; 109 Urothelial Carcinoma with Rhabdoid Differentiation; 110 Urothelial Carcinoma Similar to Giant Cell Tumor of Bone; 111 Poorly Differentiated; 112 Small Cell Carcinoma of the Urinary Bladder; 113 Large cell neuroendocrine carcinoma; 113 Well-differentiated neuroendocrine tumor; 113 Urothelial Carcinoma with Unusual Stromal Reactions; 114 Urothelial Carcinoma with Sarcomatoid Differentiation; 115 Villous Adenoma; 116 Adenocarcinoma; 117 Clear Cell Adenocarcinoma; 118 Urachal Adenocarcinoma; 119 Squamous Cell Carcinoma; 120 Paraganglioma; 121 Staging of Urothelial Carcinoma of the Urinary Bladder and Urethra; 122 Molecular Genomics of Bladder Cancer; 123 Secondary Spread of Prostate Carcinoma to the Bladder; 124 Secondary Adenocarcinoma Involving the Bladder, Other than Prostatic Carcinoma; 125 Anatomy of the Kidney; 126 Renal Dysplasia; 127 Localized Cystic Disease of the Kidney; 128 Autosomal Recessive Polycystic Kidney Disease; 129 Autosomal Dominant Polycystic Kidney Disease; 130 Medullary Sponge Kidney; 131 Acquired Cystic Kidney Disease; 132 Simple Cortical Cyst; 133 Acute Pyelonephritis; 134 Chronic Nonobstructive Pyelonephritis; 135 Chronic Obstructive Pyelonephritis; 136 Xanthogranulomatous Pyelonephritis; 137 Renal Papillary Necrosis; 138 Benign Nephrosclerosis; 139 Malignant Nephrosclerosis; 140 Acute Kidney Injury (Acute Tubular Necrosis); 141 Acute Interstitial Nephritis; 142 Infectious Interstitial Nephritis; 143 Papillary Adenoma; 144 Renal Oncocytoma; 145 Clear Cell Renal Cell Carcinoma; 146 Multilocular Cystic Renal Neoplasm of Low-Malignant Potential; 147 Papillary Renal Cell Carcinoma; 148 Renal oncocytic tumor, NOS; 148 Chromophobe Renal Cell Carcinoma; 149 Fumarate Hydratase-Deficient Renal Cell Carcinoma, Including Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome; 150 Collecting Duct Carcinoma; 151 Renal Medullary Carcinoma; 152 MiT Family Transloction Renal Cell Carcinoma; 153 Succinate Dehydrogenase-Deficient Renal Cell Carcinoma; 154 Mucinous Tubular and Spindle Cell Carcinoma; 155 Tubulocystic Carcinoma; 156 Acquired Cystic Kidney Disease-Associated Renal Cell Carcinoma; 157
• Edition: Second edition
• Publisher Details: Amsterdam : Elsevier
• Publication Date: 2021
• Extent: 1 online resource
• Subjects: 617.46; Genitourinary organs -- Diseases; Genitourinary organs -- Pathophysiology
• Languages: English
• ISBNs: 9780323653961
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.